UK: Oxford vaccine goes to human trial’s next phase

The Nation | May 23, 2020 at 9:15 AM
  • Oxford University announced that its COVID-19 vaccine has entered its next phases of human trials, according to a statement on Friday, as British health authorities announced that 351 more people died from the disease across the UK over the past 24 hours.
  • Phases II and III are now beginning.
  • Phase III will assess how the vaccine works in large numbers of people above the age of 18, and how well the vaccine prevents people becoming infected and ill with COVID-19.